Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I honestly do not know what’s worse… shorting a cancer cure stock or pretending that you product will cure cancer, while sucking the retail investors dry…
Shame on RNAz management, they should all rot in jail for fraud, with a baseball bat up the ass
May management burn in hell in rats vomit for screwing investors all their careers
Make sure you dirty rat scumbags in management show up at shareholders meeting in person, got a beautiful surprise for you dirty rat vomits scum of the earth
Relentless dumping and down 60%.
What a scam, .40 soon
Explosion monday is here brothers
This turned into a dumpster fire over the weekend.
Hold on to your dirty underwears shorts
Unfortunately this isn’t a meme stock.
Let’s push with everything we got brothers
Let’s make this happen brothers united we stand$$
Power hour for survival in this jungle!!!
churn and burn to 1.00$ All together we must push$$$
Live the short squeeze dream brothers, let’s do this now
Down 50% and not done, bottomless pit..
They wanted the RS from the beginning.Doesn't make sense,if your over a dollar, then you meet the requirements.If you need to do a RS to be over a dollar to meet the requirements.The difference is the dilution that follows.It's the fees and the transaction itself that make the insiders money.They don't care about the common shareholder,they are just the grease.All these stocks do these RS's to line their pockets.There has been more RS's this year,and it's only May,than in any other year.All these companies are doing the same things and the same capital groups are funding the RS's.Aegis Capital comes to mine.Read the paperwork people,because it's your money.Good luck and good trading.
A bounce back after such a huge drop ? It happens often.
Idiots announce an upcoming vote on a r/s when the stock was finally moving and trading up near $2 and now it tanks, . Unreal
Congrats to those who sold at $2, didn’t think we’d see these levels again.. wow
Too funny. Thanks!
Always ask yourself, if the company has a great science behind their technology, then why do an offering below 1.50. This is heading for a reverse split for sure, then another good round of dilution.
Is that all you got dirty rat shorts??now get ready to burn in hell$
No but we’ve left correction territory and entered dump city…
Any color behind this move down? Thanks
I smell news in the air dudes!!!!
Early morning selloff to the low 1.20’s, let’s see if it holds up today..
bio chart seems to be stabilized here and looks like flow is going upwards right now has 6.5m float , 2.5 months of cash and warrants at $1.22 company also had FDA clearance news earlier this month and Phase 1 trials expected to commence any day now ( Q2 2024 ) and also had $3 price target out this month as well. healthcare sector penny at same price range as ACON and known runner
HELL IS WHERE THE SHORTS BELONG FOR SUPPRESSING NEW HOPE FOR TERMINALLY ILL CANCER PATIENTS
TAKE OUT THE BREAKTHROUGH NEWS AND SHOCK THE WORLD
NEW HOPE TTX-MC138 DESERVES THE WORLDS ATTENTION FOR THE TERMINALLY ILL CANCER PATIENTS
HAIL THE HOLY GRAIL IN CANCER RESEARCH
Tomorrow is The Stars and Stripes", "Old Glory", Star-Spangled Banner" RnA Breakthrough Made in the USA
It's a full fledged war to get TTX-MC138, to the terminally ill cancer patients, we are about to witness Transcode therapeutics true power of hard work and dedication.
Blast out the news, Let’s rock and roll$$
Then I will kiss your feet… lol
What if TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and other get partnership agreement with a giant Pharma
What if TTX-MC138 gets fast track status from FDA for terminally ill cancer patients with no hope , Keep in mind they tested it already on one patient and results can follow next week
This is how I understand the proposal 4 [to grant the Board the authority to file an amendment to effect the reverse spilt in their discretion before Dec 31, 2024] see page 21-28 https://ir.transcodetherapeutics.com/static-files/2eab1bdd-3a8d-46a1-a1ad-8dfe8aa1770b 1. The primary reason for rs is to increase the stock price for the purpose of regaining $1 minimum bid requirement & raise investor interest (explained on page 22, see screen shot) 2. When the proxy material was written, the stock price was around $0.45, and the company needed a plan to increase the stock price when they appeal the decision to delist in the Hearing panel on May 14, imo. 3. On page 26, it states "The Reverse Stock Split will not be consummated, if at all, until after approval of our stockholders is obtained." So proposal 4 is to grant the Board authority to decide if R/S is needed, and if they deem so, there will be another vote [similar to last time]. Otherwise, if R/S not needed, such authority will expire by Dec 31, 2024 $RNAZ
Mark my words RNAZ'S TTX-MC138 Is the most undervalued company in all Nasdaq, It could be the next HOLO Move
This breakthrough RNA treatment has been suppressed for so long that shorts deserve to burn in hell once and for all, God bless RNAZ
Wait till the herd gets wind of this… I’m always early for a reason but 3 days is when it goes ballistic after buy in… this weekend should have more eyeballs on this. Thanks for the stock tip found this one from you on HOLO forum.. that one hits $1.50 or less it’s a buy!
Still way undervalued here, MARKET CAP
$9.26M
SHARES OUTSTANDING
6.57M
PUBLIC FLOAT
6.54M
New hope TTX-MC138 in Patients with Advanced Solid Tumors
All signs still pointing to get to about $3. After that well that’s crazy if it does
Followers
|
25
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1442
|
Created
|
04/27/21
|
Type
|
Free
|
Moderators MetaMonster |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |